Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II studyR Morant, S-F Hsu Schmitz, J Bernhard, et al.European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancerM M Borner, P Schoffski, R de Wit, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)T Ruhstaller, L Widmer, J C Schuller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2008
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKKM Borner, D Koeberle, R Von Moos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerMarkus M Borner, Daniel Dietrich, Roger Stupp, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer ResearchArnaud D Roth, Nicola Fazio, Roger Stupp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07D Helbling, G Bodoky, O Gautschi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trialW Scheithauer, J McKendrick, S Begbie, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.Ecology Letters|July 11, 2013
Conserving large populations of lions - the argument for fences has holesS Creel, M S Becker, S M Durant, et al.Pageof 8